Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Citi
Dow
Queensland Health
Healthtrust
Harvard Business School
Argus Health
Fuji
Colorcon

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,370,622

« Back to Dashboard

Which drugs does patent 9,370,622 protect, and when does it expire?

Patent 9,370,622 protects ZINGO and is included in one NDA.

This patent has nine patent family members in eight countries.
Summary for Patent: 9,370,622
Title:Devices and methods for delivering particles
Abstract: Systems, devices, and methods for delivering therapeutic particles are disclosed. In one variation, a device for delivering particles includes a gas supply configured for supplying gas under pressure, a particle cassette comprising the particles, a cassette housing, and a cassette membrane. The cassette housing can comprise an Ethylene Vinyl Acetate (EVA) copolymer of 18% to 28% by weight of Vinyl Acetate (VA). The device can also include a safety interlock to prevent or minimize the risk that the device will be unintentionally activated. The device can also have a silencer.
Inventor(s): Tsui; Victor K. (Millbrae, CA)
Assignee: Powder Pharmaceuticals Incorporated (HK)
Application Number:14/869,670
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 9,370,622

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 9,370,622

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 106163500 ➤ Try a Free Trial
China 106975128 ➤ Try a Free Trial
European Patent Office 3110404 ➤ Try a Free Trial
Japan 2017524384 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKesson
Fish and Richardson
Teva
AstraZeneca
Dow
Argus Health
Queensland Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.